<DOC>
	<DOCNO>NCT00801788</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetic profile different Egalet® oxycodone formulation compare market oxycodone product .</brief_summary>
	<brief_title>Single Dose Pharmacokinetics Egalet® Oxycodone</brief_title>
	<detailed_description />
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Main inclusion criterion : ≥18 year ≤55 year Nonsmoker BMI ≥18.0 ≤30.0 Main exclusion criterion : Any clinically significant abnormality abnormal laboratory test result find medical screen History allergic reaction opioids related drug History significant alcohol abuse drug abuse Use drug know inhibit hepatic drug metabolism Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>